Category: Clinical Breakthroughs
-
Neural Stem Cell Therapy May Improve Metastatic Cancer Survival
Neural stem cells engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2 positive breast cancer brain metastases.
-
Tumors Dramatically Shrink With New Approach to Cell Therapy
Northwestern scientists have developed a new tool to harness immune cells from tumors to fight cancer rapidly and effectively.
-
New Alternative for Relapsed B-Cell Lymphoma
A new therapy showed improvements over the standard treatment for relapsed B-cell lymphoma, according to a recent study.
-
Without Coronary Calcium, Risk Factors Impact Cardiovascular Disease
Among patients with no detectable coronary artery calcium, those who smoke, have diabetes or hypertension have the highest risk of cardiovascular disease events, according to a recent study.
-
In Cancer Treatment, Quality of Life Matters More and More
A Northwestern Medicine study has found that a new combination immune therapy treatment not only extended cancer patients’ lives better than other treatments, it also was less toxic to their overall health than other drugs on the market.
-
Improving Pre-Surgical Workups for Epilepsy
Using MRI, EEG and clinical characteristics, the pre-surgical workup can predict if patients with epilepsy will benefit from a more invasive examination.
-
Genomic Variant May Predict Cardiotoxicity From Chemotherapy
A team of investigators have discovered a novel genomic variant that may help clinicians predict which patients will experience cardiotoxicity from a widely used chemotherapy drug, according to a Northwestern Medicine study.
-
First Model to Predict Lifetime Risk of Heart Failure
A new Northwestern Medicine study has, for the first time, derived and validated a set of risk prediction models for lifetime risk of heart failure.
-
Microspheres Delay Progression of Colon Cancer
A recent study showed that targeted radioembolization alongside chemotherapy improved progress-free survival for patients with metastatic colon cancer.
-
Effectiveness of Subcutaneous Defibrillators
Electric shocks delivered by subcutaneous defibrillators are equally effective compared to shocks delivered by conventional transvenous defibrillators, according to a recent study.
